Sanofi/GlaxoSmithKline Covid-19 vaccine enters final trials
Sanofi and GlaxoSmithKline have launched a large phase 3 trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin…
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi and GlaxoSmithKline have launched a large phase 3 trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin…
The Latest: UK says variant could extend government-imposed restrictions LONDON — The British government says a fast-spreading new coronavirus variant could delay its plans to lift remaining social restrictions next month. Prime Minister Boris Johnson said Thursday that “we may need to wait” beyond the planned date of June 21. Health Secretary Matt Hancock said it was “too early now to say” whether the step could take place. Hancock said a variant of the virus first identified in India was spreading throughout the U.K. Scientists say the new strain is more transmissible than Britain...
Another Covid-19 vaccine enters final trials Top Searches Another Covid-19 vaccine enters final trials AP / May 27, 2021, 14:16 IST FacebookTwitterLinkedinEMail Representative photo PARIS: Production of another potential vaccine against Covid-19 will begin within weeks, its developers Sanofi and GlaxoSmithKline said Thursday as they launched a large Phase III trial enrolling 35,000 adult volunteers in the United States, Asia, Africa and Latin America. The study will test the effectiveness of vaccine candidate formulas against the virus that spread from Wuhan, China, and against a variant fi...
GlaxoSmithKline (GSK) is studying a COVID-19 vaccine candidate targeting the original SARS-CoV-2 strain as well as the South African B.1.351 variant. The partnership between the two companies sees Sanofi providing its recombinant antigen and GSK contributing its pandemic adjuvant, both of which have shown successful efficacy against influenza strains. Sanofi and GSK plan to enroll more than 35,000 volunteers from the U.S. and countries across Asia, Africa, and Latin America. Considering that the vaccine will be tested across multiple global sites, the investigators will also evaluate the e...
The Latest: Journal: 2 vaccines by China appear effective By The Associated Press Associated Press May 27, 2021 — 9:50am Text size Copy shortlink: JAKARTA, Indonesia — Two vaccines made by China's Sinopharm appear to be safe and effective against COVID-19, according to a study published in a medical journal. Th...